Published in Bibl Haematol on January 01, 1970
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer (1970) 5.48
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science (1981) 4.27
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses (1987) 3.67
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29
Quantitative infectivity assay for HIV-1 and-2. Nature (1988) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.86
Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol (1974) 2.84
Isolation of RD-114-like oncornavirus from a cat cell line. J Virol (1973) 2.61
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A (1987) 2.25
Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst (1969) 1.96
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol (1988) 1.95
Structure of a murine leukemia virus after disruption with tween-ether and comparison with two myxoviruses. Virology (1966) 1.88
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science (1968) 1.73
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol (1977) 1.65
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol (1987) 1.49
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology (1978) 1.42
Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol (1973) 1.41
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37
Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol (1977) 1.37
Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis. J Gen Virol (1971) 1.29
Molecular relatedness of mammalian RNA tumor viruses as determined by DNA hybridization. Science (1973) 1.28
Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus. Virology (1974) 1.28
Elimination of the sarcoma genome from murine sarcoma virus transformed cat cells. Science (1976) 1.26
Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses (1987) 1.26
Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology (1972) 1.25
Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1980) 1.24
Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology (1976) 1.19
Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus. Science (1972) 1.18
Productive infection and morphologic alteration of human cells by a modified sarcoma virus. J Natl Cancer Inst (1970) 1.17
Efficient release of murine xenotropic oncornavirus after murine leukemia virus infection of mouse cells. Virology (1975) 1.16
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1987) 1.14
Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks. Science (1978) 1.14
Radiation leukemia virus: quantitative tissue culture assay. Science (1969) 1.13
Use of an established cat cell line for investigation and quantitation of feline oncornaviruses. J Natl Cancer Inst (1972) 1.13
Viral infection across species barriers: reversible alteration of murine sarcoma virus for growth in cat cells. Science (1969) 1.13
Characterization of RNA from noninfectious virions produced by sarcoma positive-leukemia negative transformed 3T3 cells. Proc Natl Acad Sci U S A (1973) 1.11
Properties of mouse leukemia viruses. II. Isolation of viral components. Virology (1972) 1.10
Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology (1972) 1.06
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol (1987) 1.05
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Cancer Res (1985) 1.01
Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J Gen Virol (1988) 0.98
Identification of virus found in mouse lymphomas induced by HIX murine oncornavirus. J Virol (1978) 0.98
Tissue culture assay of helper activity of murine leukemia virus for murine sarcoma virus. J Natl Cancer Inst (1968) 0.98
Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology (1979) 0.98
Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Virology (1981) 0.98
Analytical techniques for cell fractions. XXVI. A two-dimentional electrophoretic analysis of basic proteins using phosphatidyl choline/urea solubilization. Anal Biochem (1979) 0.96
Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J Natl Cancer Inst (1969) 0.96
Role of carbohydrate in biological functions of Friend murine leukemia virus gp71. J Virol (1977) 0.94
Murine leukemia viruses: rupture with ether and detergents to subviral constituents. Natl Cancer Inst Monogr (1966) 0.93
Replication of radiation-induced murine leukemia virus in normal and transformed mouse cells. J Virol (1972) 0.93
Effect of helper virus on the number of murine sarcoma virus DNA copies in infected mammalian cells. J Virol (1977) 0.93
Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF. J Virol (1988) 0.93
Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus. J Gen Virol (1975) 0.92
Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice. Virology (1976) 0.92
Hemagglutination studies of the viral antigen in a murine leukemia (Rauscher). Proc Soc Exp Biol Med (1966) 0.92
Oncoduction. A unifying hypothesis of viral carcinogenesis. Prog Exp Tumor Res (1974) 0.92
Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures. J Natl Cancer Inst (1970) 0.92
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine (1989) 0.90
Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures. Virology (1985) 0.90
Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines. Cancer Res (1982) 0.89
Role of heated adenovirus 2 in viral interference. Proc Soc Exp Biol Med (1965) 0.89
Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71. Virology (1979) 0.89
The inhibition by cytosine arabinoside of the replication of murine leukemia and sarcoma viruses in mouse embryo cultures. Int J Cancer (1969) 0.88
Toward a vaccine against AIDS: rationale and current progress. Mt Sinai J Med (1986) 0.87
Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic mice. Cancer Res (1987) 0.87
Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures. Virology (1970) 0.87
Properties of mouse leukemia viruses. XIV. Prevention of spontaneous AKR leukemia by treatment with group-specific antibody against the major virus gp71 glycoprotein. Virology (1977) 0.87
The development of an AIDS vaccine: progress and promise. Public Health Rep (1988) 0.87
Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells. Proc Natl Acad Sci U S A (1981) 0.86
XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells. Virology (1982) 0.86
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J Natl Cancer Inst (1981) 0.85
Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid. Virology (1973) 0.85
Observations on the morphology of a murine leukemia virus (Rauscher) propagated in tissue culture. Natl Cancer Inst Monogr (1966) 0.84
Action of snake venom on Rauscher virus. J Natl Cancer Inst (1968) 0.83
HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus. Lancet (1986) 0.83